Terapi med stamceller til akut iskaemisk hjertesygdom, myokardial regeneration?

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Terapi med stamceller til akut iskaemisk hjertesygdom, myokardial regeneration? / Ripa, Rasmus Sejersten; Wang, Yongzhong; Jørgensen, Erik; Kastrup, Jens.

I: Ugeskrift for Laeger, Bind 169, Nr. 2, 08.01.2007, s. 119-22.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Ripa, RS, Wang, Y, Jørgensen, E & Kastrup, J 2007, 'Terapi med stamceller til akut iskaemisk hjertesygdom, myokardial regeneration?', Ugeskrift for Laeger, bind 169, nr. 2, s. 119-22.

APA

Ripa, R. S., Wang, Y., Jørgensen, E., & Kastrup, J. (2007). Terapi med stamceller til akut iskaemisk hjertesygdom, myokardial regeneration? Ugeskrift for Laeger, 169(2), 119-22.

Vancouver

Ripa RS, Wang Y, Jørgensen E, Kastrup J. Terapi med stamceller til akut iskaemisk hjertesygdom, myokardial regeneration? Ugeskrift for Laeger. 2007 jan. 8;169(2):119-22.

Author

Ripa, Rasmus Sejersten ; Wang, Yongzhong ; Jørgensen, Erik ; Kastrup, Jens. / Terapi med stamceller til akut iskaemisk hjertesygdom, myokardial regeneration?. I: Ugeskrift for Laeger. 2007 ; Bind 169, Nr. 2. s. 119-22.

Bibtex

@article{ed664d1a036d4464a877e767d8c92c81,
title = "Terapi med stamceller til akut iskaemisk hjertesygdom, myokardial regeneration?",
abstract = "Treatment of ischemic heart disease with injections of bone-marrow-derived stem cells is a promising new modality. However, recent medium-sized placebo controlled trials in patients with acute myocardial infarction have not been conclusive regarding the treatment effect. This short review aims to elucidate some of the unresolved issues raised by the first clinical trials. These include long-term safety, tissue-distribution of infused cells, selecting the optimal cell type and number, timing of the treatment, and the mechanism of a potential treatment effect.",
keywords = "Clinical Trials as Topic, Heart, Hematopoietic Stem Cell Transplantation, Humans, Myocardial Ischemia, Regeneration, Treatment Outcome",
author = "Ripa, {Rasmus Sejersten} and Yongzhong Wang and Erik J{\o}rgensen and Jens Kastrup",
year = "2007",
month = jan,
day = "8",
language = "Dansk",
volume = "169",
pages = "119--22",
journal = "Ugeskrift for Laeger",
issn = "0041-5782",
publisher = "Almindelige Danske Laegeforening",
number = "2",

}

RIS

TY - JOUR

T1 - Terapi med stamceller til akut iskaemisk hjertesygdom, myokardial regeneration?

AU - Ripa, Rasmus Sejersten

AU - Wang, Yongzhong

AU - Jørgensen, Erik

AU - Kastrup, Jens

PY - 2007/1/8

Y1 - 2007/1/8

N2 - Treatment of ischemic heart disease with injections of bone-marrow-derived stem cells is a promising new modality. However, recent medium-sized placebo controlled trials in patients with acute myocardial infarction have not been conclusive regarding the treatment effect. This short review aims to elucidate some of the unresolved issues raised by the first clinical trials. These include long-term safety, tissue-distribution of infused cells, selecting the optimal cell type and number, timing of the treatment, and the mechanism of a potential treatment effect.

AB - Treatment of ischemic heart disease with injections of bone-marrow-derived stem cells is a promising new modality. However, recent medium-sized placebo controlled trials in patients with acute myocardial infarction have not been conclusive regarding the treatment effect. This short review aims to elucidate some of the unresolved issues raised by the first clinical trials. These include long-term safety, tissue-distribution of infused cells, selecting the optimal cell type and number, timing of the treatment, and the mechanism of a potential treatment effect.

KW - Clinical Trials as Topic

KW - Heart

KW - Hematopoietic Stem Cell Transplantation

KW - Humans

KW - Myocardial Ischemia

KW - Regeneration

KW - Treatment Outcome

M3 - Tidsskriftartikel

C2 - 17227657

VL - 169

SP - 119

EP - 122

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

SN - 0041-5782

IS - 2

ER -

ID: 47744169